IL-17 is highly versatile and has been implicated in other non-pathogenic conditions including tissue repair and cancer as well42, in which IL-17 binds to recruited EGFR in the receptor complex and activates TRAF4 and subsequent signaling cascade27,39. Here, TRAF4 is linked to cancer.